Digital Imaging Analysis Reveals Reduced Alveolar α-Smooth Muscle Actin Expression in Severe Asthma.
Digital Imaging Analysis Reveals Reduced Alveolar α-Smooth Muscle Actin Expression in Severe Asthma.
复制标题
DOI:
10.1097/pai.0000000000000926
复制
发表时间:
2021-08-01
期刊:
影响因子:
--
通讯作者:
Trejo Bittar HE
中科院分区:
文献类型:
--
作者:
Jerome JA;Wenzel SE;Trejo Bittar HE
Expansion of α-smooth muscle actin(α-SMA)-expressing airway smooth muscle of the large airways in asthma is well-studied. However, the contribution of α-SMA-expressing cells in the more distal alveolated parenchyma, including pericytes and myofibroblasts within the alveolar septum, to asthma pathophysiology remains relatively unexplored. The objective of this study was to evaluate α-SMA expression in the alveolated parenchyma of individuals with severe asthma, compared to healthy controls or individuals with chronic obstructive pulmonary disease (COPD). Using quantitative digital image analysis and video-assisted thoracoscopic surgery (VATS) lung biopsies, we show that alveolated parenchyma α-SMA expression is markedly reduced in severe asthma in comparison to healthy controls (mean %positive pixels: 12% vs. 23%, p=0.005). COPD cases showed a similar, but trending, decrease in α-SMA positivity compared to controls (mean %positivity: 17% vs. 23%, p=0.107), which may suggest loss of α SMA expression is a commonality of obstructive lung diseases. The severe asthma group had similar staining for ERG, a specific endothelial marker, comparatively to controls (mean %positive nuclei: 34% vs. 42%, p=0.218), which suggests intact capillary endothelium and likely intact capillary-associated, α-SMA-positive pericytes. These findings suggest that the loss of α-SMA expression in severe asthma may be due to changes in myofibroblast α-SMA expression or cell number. Further study is necessary to fully evaluate possible mechanisms and consequences of this phenomenon.